Dose of GnRH agonist (nafarelin acetate) affects intrafollicular PAPP-A expression in controlled ovarian hyperstimulation cycle

By Suh J.   Lee E.   Hwang S.   Yoon S.   Yoon B.-K.   Bae D.   Choi D.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 112, Iss. 1, 2004-01 ,pp. : 65-68

Elsevier

Access to resources Recommend Favorite

Combined approach as an effective method in the prevention of severe ovarian hyperstimulation syndrome

By Isik A.Z.   Vicdan K.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 97, Iss. 2, 2001-08 ,pp. : 208-212

Elsevier

Access to resources Recommend Favorite

Short Communication: FSH Time-Concentration Profiles Before and After Administration of 0.25 mg Cetrorelix in the GnRH-Antagonist Multiple-Dose Protocol for Ovarian Hyperstimulation

By Griesinger G.   Finas D.   Alisch A.   Roiha K.   Schultze-Mosgau A.   Schröder A. K.   Dafopoulos K.   Diedrich K.   Felberbaum R.  

Journal of Assisted Reproduction and Genetics, Vol. 21, Iss. 7, 2004-07 ,pp. : 279-282

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy and safety of ganirelix acetate versus leuprolide acetate in women undergoing controlled ovarian hyperstimulation

By The North American Ganirelix Study Group   Fluker M.   Grifo J.   Leader A.   Levy M.   Meldrum D.   Muasher S.J.   Rinehart J.   Rosenwaks Z.   Scott R.T.   Schoolcraft W.   Shapiro D.B.   Gordon K.  

Fertility and Sterility, Vol. 75, Iss. 1, 2001-01 ,pp. : 38-45

Elsevier

Access to resources Recommend Favorite

Follicular fluid hormonal profile and cumulus cell gene expression in controlled ovarian hyperstimulation with recombinant FSH: effects of recombinant LH administration

By Barberi Marzia   Ermini Beatrice   Morelli Maria   Ermini Michele   Cecconi Sandra   Canipari Rita  

Journal of Assisted Reproduction and Genetics, Vol. 29, Iss. 12, 2012-12 ,pp. : 1381-1391

Springer Publishing Company

Access to resources Recommend Favorite